NASDAQ:CYAN

Cyanotech Stock Forecast, Price & News

$3.14

+0.05 (+1.62 %)

(As of 04/16/2021 04:00 PM ET)

Add

Compare

Today's Range

$3.06

Now: $3.14▼

$3.14

50-Day Range

$3.09

MA: $3.57▼

$4.14

52-Week Range

$2.02

Now: $3.14▼

$6.29

Volume34,892 shs

Average Volume253,480 shs

Market Capitalization$19.14 million

P/E Ratio31.40

Dividend YieldN/A

Beta0.4

Cyanotech Corporation engages in the cultivation, production, and sale of natural products derived from microalgae for the health and human nutrition markets worldwide. The company's products include BioAstin Hawaiian Astaxanthin, a dietary antioxidant, which is used as a human nutraceutical and functional food ingredient to support and maintain the body's natural inflammatory response, enhance skin, and support eye and joint health; and Hawaiian Spirulina Pacifica, a nutrient-rich dietary supplement that is used for extra energy, a strengthened immune system, cardiovascular benefits, and as a source of antioxidant carotenoids. Cyanotech Corporation sells its products as packaged consumer products through distributors, retailers, and online channels, and direct to consumers, as well as in bulk form to manufacturers, formulators, and distributors. The company was founded in 1983 and is headquartered in Kailua-Kona, Hawaii.

Industry, Sector and Symbol

Stock Exchange NASDAQ

Industry Medicinals & botanicals

Sub-IndustryN/A

SectorMedical

Current SymbolNASDAQ:CYAN

Previous Symbol

CUSIPN/A

CIK768408

Webwww.cyanotech.com

Phone808-326-1353

Employees95

Year FoundedN/A

Debt

Debt-to-Equity Ratio0.34

Current Ratio2.10

Quick Ratio0.85

Price-To-Earnings

Trailing P/E Ratio31.40

Forward P/E RatioN/A

P/E GrowthN/A

Sales & Book Value

Annual Sales$31.90 million

Price / Sales0.60

Cash Flow$0.45 per share

Price / Cash Flow7.02

Book Value$2.67 per share

Price / Book1.18

Profitability

EPS (Most Recent Fiscal Year)N/A

Net Income$390,000.00

Net Margins1.82%

Return on Equity3.67%

Return on Assets1.80%

Miscellaneous

Outstanding Shares6,097,000

Market Cap$19.14 million

Next Earnings Date6/22/2021 (Estimated)

OptionableNot Optionable

Headlines

Cyanotech Co. (NASDAQ:CYAN) Short Interest Update
April 13, 2021 | americanbankingnews.com

Microphytes Market | 2021 Global Industry Analysis By Covid-19 Impact On Healthcare Sector, Business With Forecast To 2028
March 29, 2021 | marketwatch.com

Why Cyanotech's Stock is Trading Higher Today
March 29, 2021 | finance.yahoo.com

Cyanotech Co. (NASDAQ:CYAN) Sees Large Drop in Short Interest
March 27, 2021 | americanbankingnews.com

Algae Fats Market Comprehensive Study Explores Huge Growth 2030 | Future Market Insights
March 26, 2021 | marketwatch.com

Global Algal Protein Market Size 2021 Company Overview, Growth and Forecast By 2026 Latest Research Report by Industry Research Co
March 22, 2021 | marketwatch.com

North American Algae Protein Market Size to Grow at a CAGR of 6.5% During the Forecast Period 2020–2025
March 19, 2021 | marketwatch.com

How Advancements in the food industry is Spurring Growth of Phycocyanin Market: Future Market Insights Report Analyzes
March 4, 2021 | finance.yahoo.com

Carotenoids Market Share, Development by Companies Outlook, Growth Prospects and Key Opportunities by 2030
March 4, 2021 | marketwatch.com

Cyanotech Reports Financial Results for the Third Quarter and First Nine Months of Fiscal 2021
February 11, 2021 | finance.yahoo.com

Astaxanthin Market Segments, Size, Share, Growth Opportunities, Trends, Manufacturers and Global Forecast 2026
February 7, 2021 | marketwatch.com

Marine Biotechnology Market 2021 Industry Size, Share, Price, Trend and Forecast to 2026
February 4, 2021 | marketwatch.com

Phytonutrients Market Size Report 2021 | In-Depth Market Analysis and Future Prospects Focusing on Growth Opportunities Till 2025
February 2, 2021 | marketwatch.com

Astaxanthin Market Growth, Key Players Analysis, Business Opportunities, Global Research Report 2026
January 27, 2021 | marketwatch.com

Marine Biotechnology Market 2021 to 2025 Growth Factors, Market Characteristics, Opportunities By Type Analysis and Forecast
January 27, 2021 | marketwatch.com

Pre & Post COVID-19 Market Estimates On Spirulina Market | This Market Worth $629.6 Million by 2025 Grow at a CAGR of 9.4%
January 27, 2021 | marketwatch.com

Global Microalgae Food Market - Growing Health Awareness, Rising Sustainability towards Plant-based foods driving market growth - by PMI
January 19, 2021 | marketwatch.com

Marine Algae Products Market | 12 Top Key Players Business Strategies Study Analysis (2022-2031)
January 19, 2021 | marketwatch.com

Algae Products Market : Exclusive Profitable Comprehensive Report 2020-2030 (COVID-19 UPDATES) | Koninklijke DSM N.V., BASF SE
January 15, 2021 | marketwatch.com

Algae Protein Market Size, Trends, Companies, Driver, Segmentation, Forecast to 2026
January 6, 2021 | marketwatch.com

See More Headlines

MarketRank^™

Overall MarketRank^™

0.61 out of 5 stars

Medical Sector

1368th out of 2,024 stocks

Medicinals & Botanicals Industry

17th out of 33 stocks

0.0 Analyst's Opinion

Consensus Rating
There is not enough analysis data for Cyanotech.

2.4 Community Rank

Outperform Votes
Cyanotech has received 128 “outperform” votes. (Add your “outperform” vote.)
Underperform Votes
Cyanotech has received 141 “underperform” votes. (Add your “underperform” vote.)
Community Sentiment
Cyanotech has received 52.42% “underperform” votes from our community.

MarketBeat's community ratings are surveys of what our community members think about Cyanotech and other stocks. Vote “Outperform” if you believe CYAN will outperform the S&P 500 over the long term. Vote “Underperform” if you believe CYAN will underperform the S&P 500 over the long term. You may vote once every thirty days.

0.0 Dividend Strength

Dividend Yield
Cyanotech does not currently pay a dividend.
Dividend Growth
Cyanotech does not have a long track record of dividend growth.

0.0 Company Ownership

Insider Buying vs. Insider Selling
In the past three months, Cyanotech insiders have sold more of their company's stock than they have bought. Specifically, they have bought $0.00 in company stock and sold $60,651.00 in company stock.
Percentage Held by Insiders
Only 26.20% of the stock of Cyanotech is held by insiders.
Percentage Held by Institutions
Only 11.33% of the stock of Cyanotech is held by institutions.

0.6 Earnings and Valuation

Price to Earnings Ratio vs. the Market
The P/E ratio of Cyanotech is 31.40, which means that it is trading at a more expensive P/E ratio than the market average P/E ratio of about 24.03.
Price to Earnings Ratio vs. Sector
The P/E ratio of Cyanotech is 31.40, which means that it is trading at a less expensive P/E ratio than the Medical sector average P/E ratio of about 45.43.
Price to Book Value per Share Ratio
Cyanotech has a P/B Ratio of 1.18. P/B Ratios below 3 indicates that a company is reasonably valued with respect to its assets and liabilities.

See Top Rated MarketRank™ Stocks Here

$3.14

+0.05 (+1.62 %)

(As of 04/16/2021 04:00 PM ET)

30 days | 90 days | 365 days | Advanced Chart

Receive CYAN News and Ratings via Email

Sign-up to receive the latest news and ratings for CYAN and its competitors with MarketBeat's FREE daily newsletter.

Cyanotech (NASDAQ:CYAN) Frequently Asked Questions

What stocks does MarketBeat like better than Cyanotech?

Wall Street analysts have given Cyanotech a "N/A" rating, but there may be better short-term opportunities in the market. Some of MarketBeat's past winning trading ideas have resulted in 5-15% weekly gains. MarketBeat just released five new trading ideas, but Cyanotech wasn't one of them. MarketBeat thinks these five stocks may be even better buys.
View MarketBeat's top stock picks here.

Are investors shorting Cyanotech?

Cyanotech saw a increase in short interest during the month of March. As of March 31st, there was short interest totaling 264,600 shares, an increase of 11,927.3% from the March 15th total of 2,200 shares. Based on an average daily volume of 271,300 shares, the short-interest ratio is presently 1.0 days. Approximately 5.8% of the company's stock are sold short.
View Cyanotech's Short Interest.

When is Cyanotech's next earnings date?

Cyanotech is scheduled to release its next quarterly earnings announcement on Tuesday, June 22nd 2021.
View our earnings forecast for Cyanotech.

How were Cyanotech's earnings last quarter?

Cyanotech Co. (NASDAQ:CYAN) issued its earnings results on Thursday, February, 11th. The biotechnology company reported $0.13 earnings per share for the quarter. The biotechnology company had revenue of $6.99 million for the quarter. Cyanotech had a net margin of 1.82% and a trailing twelve-month return on equity of 3.67%.
View Cyanotech's earnings history.

How has Cyanotech's stock been impacted by Coronavirus (COVID-19)?

Cyanotech's stock was trading at $1.99 on March 11th, 2020 when Coronavirus (COVID-19) reached pandemic status according to the World Health Organization. Since then, CYAN stock has increased by 57.8% and is now trading at $3.14.
View which stocks have been most impacted by COVID-19.

Who are Cyanotech's key executives?

Cyanotech's management team includes the following people:

Dr. Gerald R. Cysewski Ph.D., Co-Founder, CEO & Vice Chairman (Age 72, Pay $151.06k)
Mr. Glenn D. Jensen, VP of Operations (Age 63, Pay $177.42k)
Ms. Felicia I. Ladin, CFO & VP of Fin. & Admin. and Treasurer (Age 49)
Mr. Charles J. Hartmann, Sr. Sales & Marketing Director
Ms. Amy Beth Nordin, VP of HR & Corp. Sec. (Age 53)

What is Brent D. Bailey's approval rating as Cyanotech's CEO?

4 employees have rated Cyanotech CEO Brent D. Bailey on Glassdoor.com. Brent D. Bailey has an approval rating of 68% among Cyanotech's employees.

Who are some of Cyanotech's key competitors?

Some companies that are related to Cyanotech include Nutra Pharma (NPHC), Happiness Biotech Group (HAPP), Mannatech (MTEX), Glucose Health (GLUC), FitLife Brands (FTLF), True Drinks (TRUU), FSD Pharma (HUGE), Tauriga Sciences (TAUG), Heyu Biological Technology (HYBT), GLG Life Tech (GLGLF), Exactus (EXDI), Entia Biosciences (ERGO), Rock Creek Pharmaceuticals (RCPIQ), Beleave (BE) and Beleave (BE).
View all of CYAN's competitors.

What other stocks do shareholders of Cyanotech own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Cyanotech investors own include Allena Pharmaceuticals (ALNA), Clarivate (CCC), Gilead Sciences (GILD), Madrigal Pharmaceuticals (MDGL), Zynerba Pharmaceuticals (ZYNE), AbbVie (ABBV), AcelRx Pharmaceuticals (ACRX), Amarin (AMRN), Blackrock Resources & Commodities Strategy Trust (BCX) and Bausch Health Companies (BHC).

What is Cyanotech's stock symbol?

Cyanotech trades on the NASDAQ under the ticker symbol "CYAN."

How do I buy shares of Cyanotech?

Shares of CYAN can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

What is Cyanotech's stock price today?

One share of CYAN stock can currently be purchased for approximately $3.14.

How much money does Cyanotech make?

Cyanotech has a market capitalization of $19.14 million and generates $31.90 million in revenue each year.

How many employees does Cyanotech have?

Cyanotech employs 95 workers across the globe.

What is Cyanotech's official website?

The official website for Cyanotech is www.cyanotech.com.

Where are Cyanotech's headquarters?

Cyanotech is headquartered at 73-4460 QUEEN KAAHUMANU HWY SUITE 102, KAILUA KONA HI, 96740.

How can I contact Cyanotech?

Cyanotech's mailing address is 73-4460 QUEEN KAAHUMANU HWY SUITE 102, KAILUA KONA HI, 96740. The biotechnology company can be reached via phone at 808-326-1353 or via email at [email protected]

This page was last updated on 4/18/2021 by MarketBeat.com Staff

30 Days of MarketBeat All Access for $1.00

Best-in-Class Portfolio Monitoring
View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio.
Stock Ideas and Recommendations
Get daily stock ideas top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report.
Advanced Stock Screeners and Research Tools
Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis.

Start Your Risk-Free Trial Subscription Here